World's Best Scientists 2026 revealed!
Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
105
Citations
42508
World Ranking
6749
National Ranking
159

Ryuzo Ueda publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ryuzo Ueda sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 728 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ryuzo Ueda D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ryuzo Ueda sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Ryuzo Ueda is affiliated with Nagoya University in Japan, specializing in fields related to Medicine, Immunology, and Microbiology. Their research focuses on several subfields including Immunology, Oncology, Ecology, Evolution, Behavior and Systematics, Agronomy and Crop Science, and Molecular Biology. The scientist's main research topics include T-cell and Retrovirus Studies, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Vector-Borne Animal Diseases, Immunotherapy and Immune Responses, Animal Disease Management and Epidemiology, and CAR-T cell therapy research.

Ryuzo Ueda's recent research contributions include multiple published papers covering immunology and oncology subjects. Notable recent papers are:

  • Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab (2021, Nature Communications)
  • Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma (2021, Cancer Science)
  • Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma (2020, Blood)
  • Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers (2020, Cancer Science)
  • Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study (2020, Blood Advances)

The scientist's frequent co-authors include Susumu Suzuki, Shinsuke Iida, Takashi Ishida, Shigeru Kusumoto, and Kazuhiro Yoshikawa, reflecting collaborative work primarily within immunology and oncology research domains.

Ryuzo Ueda commonly publishes in various scientific venues, with the most frequent publication outlets being Cancer Science, British Journal of Haematology, International Journal of Molecular Sciences, Hematological Oncology, and Blood. These journals are recognized within the fields of cancer research and hematology.

Ryuzo Ueda has also contributed to book publications, including one titled New horizons for cancer research and precision medicine: extended abstracts for the 50th Commemorative International Symposium of the Princess Takamatsu Cancer Research Fund: November 12-14, 2019, Tokyo, Japan, published by Princess Takamatsu Cancer Research Fund eBooks in 2020.

Best Publications

  • Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

    Yukiya Yamamoto;Hitoshi Kiyoi;Yasuyuki Nakano;Ritsuro Suzuki

  • Prognostic Implication of FLT3 and N- RAS Gene Mutations in Acute Myeloid Leukemia

    Hitoshi Kiyoi;Tomoki Naoe;Yasuyuki Nakano;Shohei Yokota

  • Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

    Takashi Ishida;Tatsuro Joh;Naokuni Uike;Kazuhito Yamamoto

  • VCAP-AMP-VECP Compared With Biweekly CHOP for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study JCOG9801

    Kunihiro Tsukasaki;Atae Utsunomiya;Haruhiko Fukuda;Taro Shibata

  • Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma

    Rinpei Niwa;Emi Shoji-Hosaka;Mikiko Sakurada;Toyohide Shinkawa

  • Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

    Kazuhito Yamamoto;Atae Utsunomiya;Kensei Tobinai;Kunihiro Tsukasaki

  • Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho).

    H Kiyoi;T Naoe;S Yokota;M Nakao

  • Clinical Significance of CCR4 Expression in Adult T-Cell Leukemia/Lymphoma: Its Close Association with Skin Involvement and Unfavorable Outcome

    Takashi Ishida;Atae Utsunomiya;Shinsuke Iida;Hiroshi Inagaki

  • Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.

    Michinori Ogura;Takashi Ishida;Kiyohiko Hatake;Masafumi Taniwaki

  • Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin.

    Jianmin Ding;Hirokazu Komatsu;Atsushi Wakita;Miyuki Kato-Uranishi

  • Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege.

    Takashi Ishida;Toshihiko Ishii;Atsushi Inagaki;Hiroki Yano

  • Prognostic Significance of p53 Mutations and 3p Deletions in Primary Resected Non-Small Cell Lung Cancer

    Horio Y;Takahashi T;Kuroishi T;Hibi K

  • De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

    Motoko Yamaguchi;Masao Seto;Masataka Okamoto;Ryo Ichinohasama

  • Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene

    Fuminaka Sugauchi;Etsuro Orito;Takafumi Ichida;Hideaki Kato

  • Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer.

    K Hibi;T Takahashi;Y Sekido;R Ueda

  • Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

    Tatsuya Suzuki;Hitoshi Kiyoi;Kazutaka Ozeki;Akihiro Tomita

  • Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain

    Hitoshi Kiyoi;Ryuzo Ohno;Ryuzo Ueda;Hidehiko Saito

  • Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.

    Yutaka Kondo;Y. A. E. Kanai;Michiie Sakamoto;Masashi Mizokami

  • p53 Mutations in Non-Small Cell Lung Cancer in Japan: Association between Mutations and Smoking

    H Suzuki;T Takahashi;T Kuroishi;M Suyama

  • Three distinct regions involved in 3p deletion in human lung cancer.

    Hibi K;Takahashi T;Yamakawa K;Ueda R

Frequent Co-Authors

Masashi Mizokami
Masashi Mizokami National Center For Global Health and Medicine
Etsuro Orito
Etsuro Orito Japanese Red Cross Nagoya Daini Hospital
Yasuhito Tanaka
Yasuhito Tanaka Kumamoto University
Toshitada Takahashi
Toshitada Takahashi Nagoya University
Fuminaka Sugauchi
Fuminaka Sugauchi Nagoya City University
Masao Seto
Masao Seto Kurume University
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Atae Utsunomiya
Atae Utsunomiya Kagoshima University
Takashi Takahashi
Takashi Takahashi Nagoya University
Tomoki Naoe
Tomoki Naoe Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens up a variety of online educational pathways. For registered nurses wanting to become family nurse practitioners, rn to fnp programs offer flexible options and advanced credentials. These bridge programs make it easier for working professionals to upskill without pausing their careers.

Healthcare isn't limited to direct patient care. Those passionate about wellness may prefer a nutritionist online degree, which equips graduates for roles in dietetics, food consulting, and community health. With more people seeking healthy lifestyles, the field of nutrition is growing quickly.

Leadership roles in healthcare are also in demand. The best online mha programs provide management skills necessary for hospital administration and healthcare policy careers. These programs help students develop strategic thinking essential for navigating today’s complex medical environment.

If you’re a registered nurse looking to complete a bachelor’s degree efficiently, rn to bsn online no clinicals programs are an excellent choice. These degrees can be earned entirely online, making them especially convenient for working adults.

Best Scientists Citing Ryuzo Ueda

Trending Scientists

Recently Published Articles